Scilex Holding Company Dilutive Securities, Effect on Basic Earnings Per Share
Scilex Holding Company (SCLX) reported Dilutive Securities, Effect on Basic Earnings Per Share of $134.23 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:DilutiveSecurities · last filed 2023-03-07
- Scilex Holding Company dilutive securities, effect on basic earnings per share for fiscal 2022 was $134.23M, a 1.03% increase from fiscal 2021.
- Scilex Holding Company dilutive securities, effect on basic earnings per share for fiscal 2021 was $132.86M, a 0.02% decline from fiscal 2020.
- Scilex Holding Company dilutive securities, effect on basic earnings per share for fiscal 2020 was $132.89M.
| Period end | Dilutive Securities, Effect on Basic Earnings Per Share 12 month |
|---|---|
| 2022-12-31 | $134.23M 10-K · filed 2023-03-07 |
| 2021-12-31 | $132.86M 10-K · filed 2023-03-07 |
| 2020-12-31 | $132.89M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |